微创脊椎设备市场:开发平台报告(开发阶段，市场区隔，地区·国家，法规途径，主要企业等)，2023年最新版

微创脊柱融合术 (MIS) 使用空心螺钉和非空心螺钉等装置来稳定椎骨和关节。

本报告提供微创脊椎设备市场相关调查，提供产品概要与正在开发的开发中产品趋势，各种处于开发阶段产品的比较分析和进行中的临床试验相关资讯，参与企业的最近趋势等资讯。

目录

第1章 目录

第2章 简介

• 微创脊椎设备概要

第3章 开发中的产品

• 微创脊椎设备- 各开发阶段平台产品
• 微创脊椎设备- 各市场区隔开发中产品
• 微创脊椎设备- 各地区开发中产品
• 微创脊椎设备- 各法规途径开发中产品
• 微创脊椎设备- 各估计核准日开发中产品
• 微创脊椎设备- 进行中的临床试验

第4章 微创脊椎设备- 企业正在开发的开发中产品

• 微创脊椎设备企业- 各开发阶段平台产品
• 微创脊椎设备- 各开发阶段平台产品

第5章 微创脊椎设备的企业和产品概要

第6章 微创脊椎设备- 最近的开发

• 2023 年 7 月 5 日：Inspired Spine 在德国举办第三个国际实验室，展示 OLLIF 和 Trident SI 联合融合程序
• 2023年5月23日：Aurora Spine计划发布2023财年第一季度财务业绩和电话会议
• 2023 年 4 月 26 日：Aurora Spine 计划发布第四季度和 2022 财年财务业绩和电话会议
• 2023 年 2 月 16 日：Lazurite 任命医生加入医疗咨询委员会
• 2022 年 11 月 21 日：Aurora Spine 公布 2022 年第三季度财务业绩
• 2022年10月12日：奥罗拉脊柱公司将出席北美脊柱学会年会

第7章 附录

• 调查手法
• 关于GlobalData
• 询问
• 免责声明

Abstract

GlobalData's Medical Devices sector report, "Minimal Invasive Spinal Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Minimal Invasive Spinal Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Minimally Invasive Spine (MIS) fusion surgery is performed to stabilize the vertebral bones and joints using devices such as Cannulated and non-Cannulated screws.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Minimal Invasive Spinal Devices under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Minimal Invasive Spinal Devices and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Minimal Invasive Spinal Devices under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Minimal Invasive Spinal Devices Overview

3 Products under Development

• 3.1 Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
• 3.2 Minimal Invasive Spinal Devices - Pipeline Products by Segment
• 3.3 Minimal Invasive Spinal Devices - Pipeline Products by Territory
• 3.4 Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path
• 3.5 Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
• 3.6 Minimal Invasive Spinal Devices - Ongoing Clinical Trials

4 Minimal Invasive Spinal Devices - Pipeline Products under Development by Companies

• 4.1 Minimal Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
• 4.2 Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development

5 Minimal Invasive Spinal Devices Companies and Product Overview

6 Minimal Invasive Spinal Devices- Recent Developments

• 6.1 Jul 05, 2023: Inspired Spine Hosts Third International Lab in Germany, Showcasing OLLIF and Trident SI Joint Fusion Procedures
• 6.2 May 23, 2023: Aurora Spine schedules release of Q1 fiscal year 2023 financial results and conference call
• 6.3 Apr 26, 2023: Aurora Spine schedules release of Q4 and fiscal year 2022 financial results and conference call
• 6.4 Feb 16, 2023: Lazurite Names Physicians to Medical Advisory Board
• 6.5 Nov 21, 2022: Aurora Spine Announces Third Quarter Fiscal 2022 Financial Results
• 6.6 Oct 12, 2022: Aurora Spine Corporation to Attend the North American Spine Society Annual Meeting

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

List of Tables

• Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
• Minimal Invasive Spinal Devices - Pipeline Products by Segment
• Minimal Invasive Spinal Devices - Pipeline Products by Territory
• Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path
• Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
• Minimal Invasive Spinal Devices - Ongoing Clinical Trials
• Minimal Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
• Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
• Glossary

List of Figures

List of Figures

• Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
• Minimal Invasive Spinal Devices - Pipeline Products by Segment
• Minimal Invasive Spinal Devices - Pipeline Products by Territory
• Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path
• Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
• Minimal Invasive Spinal Devices - Ongoing Clinical Trials